| Document Date: 2014-12-05 11:54:54
Open Document File Size: 679,95 KBShare Result on Facebook
Company Serogroup / Public Health Ontario Laboratories / / Country Canada / / IndustryTerm symptomatic carrier / / MedicalCondition serious diseases / allergies / invasive meningococcal disease / Neisserria meningitis / HIV / N. meningitis / Disease / meningococcal meningitis / coma / acquired complement deficiency / anaphylaxis / septicemia / vomiting / D Deficiency / meningococcal disease / Guillian-Barré Syndrome / severe headache / anaphylactic hypersensitivity / disorder / widespread infection / infection / hearing loss / high fever / rash / meningitis / very serious infection / serious illness / / MedicalTreatment immunization / Cochlear implant / active immunization / immunization schedule / / Organization IMD / National Advisory Committee on Immunization / Public Health Agency of Canada / IMD in Ontario / Ministry of Health / / Position Queen / Governor / registered nurse / nurse / physician / / ProvinceOrState Ontario / / Technology pdf / / URL www.health.gov.on.ca/en/pro/programs/immunization / www.phdapps.health.gov.on.ca/PHULocator / www.health.gov.on.ca/en/common/system/services/phu/locations.aspx / www.vaccineshoppecanada.com/document.cfm?file=menactra_e.pdf / www.ontario.ca/vaccines / www.publichealthontario.ca/en/BrowseByTopic/InfectiousDiseases/Pages/ImmunizationResources.aspx / www.health.gov.on.ca/en/pro/programs/publichealth/oph_standards/docs/guidance/guide_vaccine_stora / /
SocialTag |
Public Health Division Quadrivalent meningococcal ACYW-135 vaccine (Menactra®): Q&A for health care providers This questions and answers sheet for health care professionals provides basic information only. It is not in